Positive and negative regulatory elements for the expression of the Alzheimer's disease amyloid precursor-encoding gene in mouse.
暂无分享,去创建一个
M. Hattori | Y. Sakaki | S. Yoshikai | H. Sasaki | T. Yamada | R. Izumi
[1] T. Ogihara,et al. The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. , 1991, Biochemical and biophysical research communications.
[2] B. Trapp,et al. Deposits of amyloid beta protein in the central nervous system of transgenic mice. , 1991, Science.
[3] K. Murakami,et al. Formation of β-amyloid protein deposits in brains of transgenic mice , 1991, Nature.
[4] S. Tsuji,et al. Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease , 1991, The Lancet.
[5] M. Pericak-Vance,et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.
[6] B. Trapp,et al. Regulatory region of human amyloid precursor protein (APP) gene promotes neuron‐specific gene expression in the CNS of transgenic mice. , 1991, The EMBO journal.
[7] N. Robakis,et al. The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. , 1991, Brain research. Molecular brain research.
[8] Y. Sakaki,et al. Genomic organization of the human-amyloid beta-protein precursor gene. , 1990, Gene.
[9] D. Brenner,et al. A simplified method for the preparation of transcriptionally active liver nuclear extracts. , 1990, DNA and cell biology.
[10] C. Finch,et al. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.
[11] M. Hattori,et al. Acute-phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat alpha 2-macroglobulin gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Kimura,et al. Tissue-specific expression of three types of β-protein precursor mRNA: Enhancement of protease inhibitor-harboring types in Alzheimer's disease brain , 1989 .
[13] I. Pastan,et al. Molecular cloning and characterization of a human DNA binding factor that represses transcription , 1989, Cell.
[14] H. W. Harris,et al. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] Robert B. Nelson,et al. Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.
[16] Y. Sakaki,et al. Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor. , 1989, Biochemical and biophysical research communications.
[17] K. Beyreuther,et al. The promoter of Alzheimer's disease amyloid A4 precursor gene. , 1988, Progress in clinical and biological research.
[18] W. Schaffner,et al. Identification of a novel lymphoid specific octamer binding protein (OTF‐2B) by proteolytic clipping bandshift assay (PCBA). , 1988, The EMBO journal.
[19] S. Prusiner,et al. Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[20] Steven A. Johnson,et al. Selective reduction of mRNA for the β-amyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer brains , 1988, Experimental Neurology.
[21] R. Tjian,et al. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro , 1988, Nature.
[22] S. Shiojiri,et al. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.
[23] L. Villa-komaroff,et al. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease , 1988, Nature.
[24] B. Greenberg,et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.
[25] P. Sharp,et al. A high-efficiency HeLa cell nuclear transcription extract. , 1988, DNA.
[26] Y. Sakaki,et al. Complementary DNA for the mouse homolog of the human amyloid beta protein precursor. , 1987, Biochemical and biophysical research communications.
[27] K. Wood,et al. Firefly luciferase gene: structure and expression in mammalian cells , 1987, Molecular and cellular biology.
[28] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[29] A. Heguy,et al. Metal-responsive elements act as positive modulators of human metallothionein-IIA enhancer activity , 1987, Molecular and cellular biology.
[30] M. Hattori,et al. Dideoxy sequencing method using denatured plasmid templates. , 1986, Analytical biochemistry.
[31] Robert Tjian,et al. Promoter-specific activation of RNA polymerase II transcription by Sp1 , 1986 .
[32] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[33] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[34] B. Howard,et al. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.
[35] D. Galas,et al. DNAse footprinting: a simple method for the detection of protein-DNA binding specificity. , 1978, Nucleic acids research.
[36] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.